IL-17 antibody

Synonyms:CTLA 8 antibody, CTLA8 antibody, IL 17 antibody, IL 17A antibody, IL17 antibody, IL-17 antibody, IL17A antibody, interleukin 17A antibody
Catalogue No.:FNab04225Reactivity:Human
Host:MouseTested Application:ELISA, WB, FC
Clonality:monoclonalIsotype:IgG1
  • SPECIFICATIONS
Product Name
IL-17 antibody
Catalogue No.
FNab04225
Size
100μg
Form
liquid
Purification
Protein A+G purification
Purity
≥95% as determined by SDS-PAGE
Clonality
monoclonal
Isotype
IgG1
Clone ID
5E2
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
interleukin 17A
Alternative Names
CTLA 8 antibody, CTLA8 antibody, IL 17 antibody, IL 17A antibody, IL17 antibody, IL-17 antibody, IL17A antibody, interleukin 17A antibody
UniProt ID
Q16552
Observed MW
18 kDa
Application
Tested Applications
ELISA, WB, FC
Recommended dilution
WB: 1:500-1:1000
Validated Images
U-937 cells were subjected to SDS PAGE followed by western blot with FNab04225(IL-17 antibody) at dilution of 1:500
Background
IL17A, also named as IL-17, is a proinflammatory cytokine. IL-17, synthesized only by memory T cells and natural killer cells, has pleiotropic effects, mainly in the recruitment and activation of neutrophils. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2(PTGS2/COX-2), as well as enhance the production of nitric oxide(NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The IL-17 receptor is a type I transmembrane protein, that is widely expressed on epithelial cells, fibroblasts, B and T cells, and monocytic cells. In psoriatic skin lesions, both Th17 cells and their downstream effector molecules, e.g. IL-17 and IL-22, are highly increased.